Nov 12 (Reuters) - Irongate Group (IAP) : JSE: IAP - IRONGATE GROUP REJECTS REVISED INDICATIVE PROPOSAL FROM 360 CAPITAL
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status